ViraCor Laboratories Launches Ultrasensitive JC Virus Test

KANSAS CITY, Mo.--(BUSINESS WIRE)--ViraCor Laboratories, the leader in molecular diagnostic testing for infectious diseases, today announced the launch of a new ultrasensitive molecular test to detect JC Virus in cerebral spinal fluid (CSF). The second JCV test to be developed in ViraCor's laboratories, the ultrasensitive JCV PCR test can accurately detect the virus in a patient sample with as few as 25 viral copies per milliliter of sample.